(Reuters) – Canada on Thursday authorized Moderna Inc’s bivalent COVID-19 vaccine booster for people aged 18 and older, according to a notice posted on the government’s website.
The new so-called bivalent shots are designed to target the BA.1 version of Omicron and the original virus.
(Reporting by Ismail Shakil in Ottawa; Editing by Chizu Nomiyama)
